![]() |

![]() |
Create Name: | |
Description: |
![]() |
Save what matters to you |
{{ loginError }} |
Sign in with your RGD account |
Create New Account | Recover Password |
Analyze GeneStrainQTL List |
![]() Gene Annotator (Functional Annotation) unavailable |
![]() Gene Annotator (Annotation Distribution) unavailable |
![]() Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
![]() InterViewer (Protein-Protein Interactions) unavailable |
![]() Gviewer (Genome Viewer) unavailable |
![]() Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
![]() Gene Annotator (Annotation Comparison) unavailable |
![]() OLGA (Gene List Generator) unavailable |
![]() |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
![]() MOET (Multi-Ontology Enrichement) unavailable |
![]() GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
![]() Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of FRMD3 mRNA | CTD | PMID:23019147 | 17beta-estradiol | multiple interactions | ISO | RGD:1304802 | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of FRMD3 mRNA | CTD | PMID:26496021 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of FRMD3 mRNA | CTD | PMID:20660070 | acrylamide | decreases expression | ISO | RGD:1304802 | 6480464 | Acrylamide results in decreased expression of FRMD3 mRNA | CTD | PMID:28959563 | aflatoxin B2 | increases methylation | EXP | | 6480464 | aflatoxin B2 results in increased methylation of FRMD3 intron | CTD | PMID:30157460 | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of FRMD3 mRNA | CTD | PMID:23724009 | amiodarone | increases expression | EXP | | 6480464 | Amiodarone results in increased expression of FRMD3 mRNA | CTD | PMID:19774075 | arsenite(3-) | increases methylation | EXP | | 6480464 | arsenite results in increased methylation of FRMD3 promoter | CTD | PMID:23974009 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of FRMD3 mRNA | CTD | PMID:20106945, PMID:21632981 | benzo[a]pyrene diol epoxide I | decreases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:20018196 | bisphenol A | multiple interactions | ISO | RGD:1304802 | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of FRMD3 mRNA | CTD | PMID:26496021 | bisphenol A | affects methylation | ISO | RGD:1312460 | 6480464 | bisphenol A affects the methylation of FRMD3 promoter | CTD | PMID:27334623 | bisphenol A | decreases expression | ISO | RGD:1304802 | 6480464 | bisphenol A results in decreased expression of FRMD3 mRNA | CTD | PMID:25181051 | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of FRMD3 mRNA | CTD | PMID:27392435 | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of FRMD3 mRNA | CTD | PMID:27392435 | coumestrol | decreases expression | EXP | | 6480464 | Coumestrol results in decreased expression of FRMD3 mRNA | CTD | PMID:19167446 | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of FRMD3 mRNA | CTD | PMID:20106945, PMID:21632981 | DDT | decreases expression | ISO | RGD:1304802 | 6480464 | DDT results in decreased expression of FRMD3 mRNA | CTD | PMID:30207508 | dioxygen | increases expression | ISO | RGD:1312460 | 6480464 | Oxygen deficiency results in increased expression of FRMD3 mRNA | CTD | PMID:20880076 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of FRMD3 mRNA | CTD | PMID:29803840 | formaldehyde | increases expression | EXP | | 6480464 | Formaldehyde results in increased expression of FRMD3 mRNA | CTD | PMID:23649840 | lead diacetate | decreases expression | ISO | RGD:1312460 | 6480464 | lead acetate results in decreased expression of FRMD3 mRNA | CTD | PMID:22613225 | leflunomide | increases expression | EXP | | 6480464 | leflunomide results in increased expression of FRMD3 mRNA | CTD | PMID:28988120 | mercury dibromide | decreases expression | EXP | | 6480464 | mercuric bromide results in decreased expression of FRMD3 mRNA | CTD | PMID:26272509 | mercury dibromide | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FRMD3 mRNA | CTD | PMID:27188386 | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of FRMD3 mRNA | CTD | PMID:28001369 | nickel sulfate | increases expression | EXP | | 6480464 | nickel sulfate results in increased expression of FRMD3 mRNA | CTD | PMID:22714537 | ochratoxin A | increases expression | EXP | | 6480464 | ochratoxin A results in increased expression of FRMD3 mRNA | CTD | PMID:30559759 | p-chloromercuribenzoic acid | decreases expression | EXP | | 6480464 | p-Chloromercuribenzoic Acid results in decreased expression of FRMD3 mRNA | CTD | PMID:26272509 | p-chloromercuribenzoic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FRMD3 mRNA | CTD | PMID:27188386 | phenylmercury acetate | decreases expression | EXP | | 6480464 | Phenylmercuric Acetate results in decreased expression of FRMD3 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FRMD3 mRNA | CTD | PMID:27188386 | pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of FRMD3 mRNA | CTD | PMID:19710929 | progesterone | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of FRMD3 mRNA | CTD | PMID:20660070 | protein kinase inhibitor | multiple interactions | EXP | | 6480464 | Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of FRMD3 mRNA] | CTD | PMID:28003376 | quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of FRMD3 mRNA | CTD | PMID:21632981 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide analog results in decreased expression of FRMD3 mRNA | CTD | PMID:25895662 | sodium arsenite | multiple interactions | EXP | | 6480464 | sodium arsenite results in decreased expression of and affects the splicing of FRMD3 mRNA | CTD | PMID:25879800 | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of FRMD3 mRNA | CTD | PMID:24935251 | triclosan | decreases expression | EXP | | 6480464 | Triclosan results in decreased expression of FRMD3 mRNA | CTD | PMID:30510588 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of FRMD3 mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | ISO | RGD:1312460 | 6480464 | Valproic Acid results in decreased expression of FRMD3 mRNA | CTD | PMID:24896083 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of FRMD3 mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FRMD3 mRNA | CTD | PMID:27188386 | |
|
|
|
|
|
|
|
|
1. | RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations |
2. | RGD automated import pipeline for gene-chemical interactions |
3. | Strausberg RL, etal., Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16899-903. Epub 2002 Dec 11. |
PubMed | 8125298 12601556 14702039 17260017 19252134 20379614 20460425 21698141 21873635 23434934 24366813 26909942 28514442 28611215 |
FRMD3 (Homo sapiens - human) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Frmd3 (Mus musculus - house mouse) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Frmd3 (Rattus norvegicus - Norway rat) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Frmd3 (Chinchilla lanigera - long-tailed chinchilla) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
FRMD3 (Pan paniscus - bonobo/pygmy chimpanzee) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
FRMD3 (Canis lupus familiaris - dog) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Frmd3 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
FRMD3 (Sus scrofa - pig) |
|
D9S152 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RH68275 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RH92879 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SHGC-80898 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SHGC-111546 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SHGC-156240 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
D9S2153 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
FRMD3__6754 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
D9S2150 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
D9S1733 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
D9S152 |
|
The detailed report is available here: | ![]() | Full Report | ![]() | CSV | ![]() | TAB | ![]() | Printer |
miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/). For more information about miRGate, see PMID:25858286 or access the full paper here. |
RefSeq Transcripts | NM_001244959 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
NM_001244960 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
NM_001244961 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
NM_001244962 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
NM_001375487 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
NM_174938 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_017014588 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_017014589 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_017014591 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_024447487 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_024447488 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_024447489 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
GenBank Nucleotide | AK094281 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
AK223597 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK297722 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AL137847 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AL161786 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AL353641 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AL354920 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AL450026 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AY137774 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BC023560 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BC037253 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BC041376 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BM873990 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BX647549 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
CH471089 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
EF560742 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
RefSeq Acc Id: | NM_001244959 ⟹ NP_001231888 | ||||||||||||||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||
Sequence: |
GGAGGCGAGCGAACAGAGGGAGGGACCCGCCCGCCGCGCCCCGGCCGCTGGGCATGTGTGTCCGhide sequence |
RefSeq Acc Id: | NM_001244960 ⟹ NP_001231889 | ||||||||||||||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||
Sequence: |
AGCCCTAGAGCTCCCAGAGACAGAAGACGAGATGGCAGTATTTTAAGGCACTAGCAGATCACGGhide sequence |
RefSeq Acc Id: | NM_001244961 ⟹ NP_001231890 | ||||||||||||||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||
Sequence: |
GCTTCATTTCGGAAGTGATTCATAGCACTTCTGCTTACAACTCTCTGATCAGGACTCATCCCAAhide sequence |
RefSeq Acc Id: | NM_001244962 ⟹ NP_001231891 | ||||||||||||||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||
Sequence: |
TGAGTTATTTCTGTTGGCCGCATTAGGAACCTGACATTTGATTCATTCAGTGGGTCCTGCCTAGhide sequence |
RefSeq Acc Id: | NM_174938 ⟹ NP_777598 | ||||||||||||||||||||||||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||||||||||||
Sequence: |
GGAGGCGAGCGAACAGAGGGAGGGACCCGCCCGCCGCGCCCCGGCCGCTGGGCATGTGTGTCCGhide sequence |
RefSeq Acc Id: | XM_017014588 ⟹ XP_016870077 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
CTGTTCTACTGGGAGATGCTGCAAACTCGCACTGCCAAGAGGGAAACCAAAGGGCAGTTTCTCAhide sequence |
RefSeq Acc Id: | XM_017014589 ⟹ XP_016870078 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
TTTATGCCCTGTGTGATGGTTACACTCTACATGGGCTGCTGGGAATCAAATGAAGTGTGTGTAGhide sequence |
RefSeq Acc Id: | XM_017014591 ⟹ XP_016870080 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
CTGATCCCTCATGAGTTATTTCTGTTGGCCGCATTAGGAACCTGACATTTGATTCATTCAGTGGhide sequence |
RefSeq Acc Id: | XM_024447487 ⟹ XP_024303255 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
ACATTTGTGTGCATGTATCAGAAAACCAAAAAATAACAATAGCTTAGATAAGTTGGAAGTTTAThide sequence |
RefSeq Acc Id: | XM_024447488 ⟹ XP_024303256 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
TATATATGTATTATATATATTCTAGTTCTTTGGTGAAATTGTCACCCATTTTCTTAAACATGTThide sequence |
RefSeq Acc Id: | XM_024447489 ⟹ XP_024303257 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
TTTGATTAGGACTAAACCCCTCGTTCTAGTTCATTATCGAAATTGGGTTTCATTCCTGCTAATAhide sequence |
Protein RefSeqs | NP_001231888 | (Get FASTA) | NCBI Sequence Viewer |
NP_001231889 | (Get FASTA) | NCBI Sequence Viewer | |
NP_001231890 | (Get FASTA) | NCBI Sequence Viewer | |
NP_001231891 | (Get FASTA) | NCBI Sequence Viewer | |
NP_001362416 | (Get FASTA) | NCBI Sequence Viewer | |
NP_777598 | (Get FASTA) | NCBI Sequence Viewer | |
XP_016870077 | (Get FASTA) | NCBI Sequence Viewer | |
XP_016870078 | (Get FASTA) | NCBI Sequence Viewer | |
XP_016870080 | (Get FASTA) | NCBI Sequence Viewer | |
XP_024303255 | (Get FASTA) | NCBI Sequence Viewer | |
XP_024303256 | (Get FASTA) | NCBI Sequence Viewer | |
XP_024303257 | (Get FASTA) | NCBI Sequence Viewer | |
GenBank Protein | A2A2Y4 | (Get FASTA) | NCBI Sequence Viewer |
AAH23560 | (Get FASTA) | NCBI Sequence Viewer | |
AAH37253 | (Get FASTA) | NCBI Sequence Viewer | |
AAN52119 | (Get FASTA) | NCBI Sequence Viewer | |
ABQ59052 | (Get FASTA) | NCBI Sequence Viewer | |
BAC04321 | (Get FASTA) | NCBI Sequence Viewer | |
BAD97317 | (Get FASTA) | NCBI Sequence Viewer | |
BAG60076 | (Get FASTA) | NCBI Sequence Viewer | |
EAW62647 | (Get FASTA) | NCBI Sequence Viewer | |
EAW62648 | (Get FASTA) | NCBI Sequence Viewer | |
EAW62649 | (Get FASTA) | NCBI Sequence Viewer | |
EAW62650 | (Get FASTA) | NCBI Sequence Viewer | |
EAW62651 | (Get FASTA) | NCBI Sequence Viewer |
RefSeq Acc Id: | NP_777598 ⟸ NM_174938 |
- Peptide Label: | isoform 1 |
- UniProtKB: | A2A2Y4 (UniProtKB/Swiss-Prot) |
- Sequence: |
MFASCHCVPRGRRTMKMIHFRSSSVKSLSQEMRCTIRLLDDSEISCHIQRETKGQFLIDHICNYhide sequence |
RefSeq Acc Id: | NP_001231888 ⟸ NM_001244959 |
- Peptide Label: | isoform 2 |
- UniProtKB: | A2A2Y4 (UniProtKB/Swiss-Prot) |
- Sequence: |
MFASCHCVPRGRRTMKMIHFRSSSVKSLSQEMRCTIRLLDDSEISCHIQRETKGQFLIDHICNYhide sequence |
RefSeq Acc Id: | NP_001231890 ⟸ NM_001244961 |
- Peptide Label: | isoform 4 |
- UniProtKB: | A2A2Y4 (UniProtKB/Swiss-Prot) |
- Sequence: |
MVFRRGQSPPVAEFNLLLKAHTLETYGVDPHPCKDSTGTTTFLGFTAAGFVVFQGNKRIHLIKWhide sequence |
RefSeq Acc Id: | NP_001231891 ⟸ NM_001244962 |
- Peptide Label: | isoform 5 |
- UniProtKB: | A2A2Y4 (UniProtKB/Swiss-Prot) |
- Sequence: |
MQAEETKGIGITSMAKCLVKIQTRRSLQLHMVNHCNSNVFVRLLRLGSKVTARNTGVPLPKEENhide sequence |
RefSeq Acc Id: | NP_001231889 ⟸ NM_001244960 |
- Peptide Label: | isoform 3 |
- UniProtKB: | A2A2Y4 (UniProtKB/Swiss-Prot) |
- Sequence: |
MQLSKRETKGQFLIDHICNYYSLLEKDYFGIRYVDPEKQRHWLEPNKSIFKQMKTHPPYTMCFRhide sequence |
RefSeq Acc Id: | XP_016870077 ⟸ XM_017014588 |
- Peptide Label: | isoform X1 |
- Sequence: |
MLQTRTAKRETKGQFLIDHICNYYSLLEKDYFGIRYVDPEKQRHWLEPNKSIFKQMKTHPPYTMhide sequence |
RefSeq Acc Id: | XP_016870078 ⟸ XM_017014589 |
- Peptide Label: | isoform X3 |
- Sequence: |
MVFRRGQSPPVAEFNLLLKAHTLETYGVDPHPCKDSTGTTTFLGFTAAGFVVFQGNKRIHLIKWhide sequence |
RefSeq Acc Id: | XP_016870080 ⟸ XM_017014591 |
- Peptide Label: | isoform X4 |
- Sequence: |
MQAEETKGIGITSMAKCLVKIQTRRSLQLHMVNHCNSNVFVRLLRLGSKVTARNTGVPLPKEENhide sequence |
RefSeq Acc Id: | XP_024303255 ⟸ XM_024447487 |
- Peptide Label: | isoform X2 |
- Sequence: |
MKTHPPYTMCFRVKFYPHEPLKIKEELTRYLLYLQIKRDIFHGRLLCSFSDAAYLGACIVQAELhide sequence |
RefSeq Acc Id: | XP_024303257 ⟸ XM_024447489 |
- Peptide Label: | isoform X2 |
- Sequence: |
MKTHPPYTMCFRVKFYPHEPLKIKEELTRYLLYLQIKRDIFHGRLLCSFSDAAYLGACIVQAELhide sequence |
RefSeq Acc Id: | XP_024303256 ⟸ XM_024447488 |
- Peptide Label: | isoform X2 |
- Sequence: |
MKTHPPYTMCFRVKFYPHEPLKIKEELTRYLLYLQIKRDIFHGRLLCSFSDAAYLGACIVQAELhide sequence |
RGD ID: | 7215311 | |||||||||
Promoter ID: | EPDNEW_H13402 | |||||||||
Type: | initiation region | |||||||||
Name: | FRMD3_2 | |||||||||
Description: | FERM domain containing 3 | |||||||||
SO ACC ID: | SO:0000170 | |||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | |||||||||
Experiment Methods: | Single-end sequencing. | |||||||||
Position: |
|
RGD ID: | 7215313 | |||||||||
Promoter ID: | EPDNEW_H13403 | |||||||||
Type: | initiation region | |||||||||
Name: | FRMD3_1 | |||||||||
Description: | FERM domain containing 3 | |||||||||
SO ACC ID: | SO:0000170 | |||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | |||||||||
Experiment Methods: | Single-end sequencing. | |||||||||
Position: |
|
RGD ID: | 7215315 | |||||||||
Promoter ID: | EPDNEW_H13404 | |||||||||
Type: | initiation region | |||||||||
Name: | FRMD3_4 | |||||||||
Description: | FERM domain containing 3 | |||||||||
SO ACC ID: | SO:0000170 | |||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | |||||||||
Experiment Methods: | Single-end sequencing.; Paired-end sequencing. | |||||||||
Position: |
|
RGD ID: | 6807717 | |||||||||
Promoter ID: | HG_KWN:63821 | |||||||||
Type: | CpG-Island | |||||||||
SO ACC ID: | SO:0000170 | |||||||||
Source: | MPROMDB | |||||||||
Tissues & Cell Lines: | HeLa_S3 | |||||||||
Transcripts: | ENST00000376422, ENST00000376427, ENST00000376438, ENST00000406518 | |||||||||
Position: |
|
Name | Type | Condition(s) | Position(s) | Clinical significance |
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138179445)x3 | copy number gain | Global developmental delay [RCV000050347]|Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000050348]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000050348]|See cases [RCV000050348] | Chr9:193412..138179445 [GRCh38] Chr9:204193..141073897 [GRCh37] Chr9:194193..140193718 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138124532)x3 | copy number gain | Intrauterine growth retardation [RCV000053745]|See cases [RCV000053745] | Chr9:193412..138124532 [GRCh38] Chr9:204193..141018984 [GRCh37] Chr9:194193..140138805 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138114463)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053746]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053746]|See cases [RCV000053746] | Chr9:193412..138114463 [GRCh38] Chr9:214367..141008915 [GRCh37] Chr9:204367..140128736 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138179445)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053748]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053748]|See cases [RCV000053748] | Chr9:193412..138179445 [GRCh38] Chr9:266045..141073897 [GRCh37] Chr9:256045..140193718 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic |
NM_174938.5(FRMD3):c.1540A>C (p.Ile514Leu) | single nucleotide variant | Malignant melanoma [RCV000068722] | Chr9:83248172 [GRCh38] Chr9:85863087 [GRCh37] Chr9:85052907 [NCBI36] Chr9:9q21.32 |
not provided |
GRCh38/hg38 9p24.3-q34.3(chr9:204193-138179445) | copy number gain | See cases [RCV000133791] | Chr9:204193..138179445 [GRCh38] Chr9:204193..141073897 [GRCh37] Chr9:194193..140193718 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh38/hg38 9q21.11-31.2(chr9:68420430-106579493)x3 | copy number gain | See cases [RCV000136788] | Chr9:68420430..106579493 [GRCh38] Chr9:71130848..109341774 [GRCh37] Chr9:70225166..108381595 [NCBI36] Chr9:9q21.11-31.2 |
pathogenic |
GRCh38/hg38 9q21.11-21.32(chr9:68499530-83670227)x1 | copy number loss | See cases [RCV000137963] | Chr9:68499530..83670227 [GRCh38] Chr9:71130848..86285142 [GRCh37] Chr9:70304266..85474962 [NCBI36] Chr9:9q21.11-21.32 |
pathogenic |
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138124524)x3 | copy number gain | See cases [RCV000138783] | Chr9:193412..138124524 [GRCh38] Chr9:204090..141018976 [GRCh37] Chr9:194090..140138797 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh38/hg38 9p11.2-q34.3(chr9:193412-138159073)x3 | copy number gain | See cases [RCV000139207] | Chr9:193412..138159073 [GRCh38] Chr9:68420641..141053525 [GRCh37] Chr9:67910461..140173346 [NCBI36] Chr9:9p11.2-q34.3 |
pathogenic |
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138159073)x3 | copy number gain | See cases [RCV000138962] | Chr9:193412..138159073 [GRCh38] Chr9:204104..141053525 [GRCh37] Chr9:194104..140173346 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic|conflicting data from submitters |
GRCh38/hg38 9q21.12-31.3(chr9:69627642-111454304)x3 | copy number gain | See cases [RCV000139789] | Chr9:69627642..111454304 [GRCh38] Chr9:72242558..114216584 [GRCh37] Chr9:71432378..113256405 [NCBI36] Chr9:9q21.12-31.3 |
pathogenic |
GRCh38/hg38 9p24.3-q22.1(chr9:203861-88130444)x4 | copy number gain | See cases [RCV000141904] | Chr9:203861..88130444 [GRCh38] Chr9:203861..90745359 [GRCh37] Chr9:193861..89935179 [NCBI36] Chr9:9p24.3-q22.1 |
pathogenic |
GRCh38/hg38 9p24.3-q34.3(chr9:203861-138125937)x3 | copy number gain | See cases [RCV000141876] | Chr9:203861..138125937 [GRCh38] Chr9:203861..141020389 [GRCh37] Chr9:193861..140140210 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh38/hg38 9p24.3-q34.3(chr9:203862-138125937)x3 | copy number gain | See cases [RCV000143476] | Chr9:203862..138125937 [GRCh38] Chr9:203862..141020389 [GRCh37] Chr9:193862..140140210 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138179445)x3 | copy number gain | See cases [RCV000148113] | Chr9:193412..138179445 [GRCh38] Chr9:204193..141073897 [GRCh37] Chr9:194193..140193718 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9p24.3-q34.3(chr9:163131-141122114)x3 | copy number gain | See cases [RCV000240081] | Chr9:163131..141122114 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9p24.3-q34.3(chr9:62525-141006407) | copy number gain | See cases [RCV000449375] | Chr9:62525..141006407 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9p24.3-q34.3(chr9:203861-141020389)x3 | copy number gain | See cases [RCV000447207] | Chr9:203861..141020389 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9p24.3-q34.3(chr9:203864-141020389)x3 | copy number gain | See cases [RCV000448978] | Chr9:203864..141020389 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9q21.11-34.3(chr9:71069743-140999928) | copy number gain | Global developmental delay [RCV000626548]|Seizures [RCV000626548] | Chr9:71069743..140999928 [GRCh37] Chr9:9q21.11-34.3 |
likely pathogenic |
GRCh37/hg19 9q21.11-22.1(chr9:70966262-90761254)x4 | copy number gain | See cases [RCV000512280] | Chr9:70966262..90761254 [GRCh37] Chr9:9q21.11-22.1 |
pathogenic |
GRCh37/hg19 9p24.3-q21.33(chr9:203861-88189913)x3 | copy number gain | See cases [RCV000512431] | Chr9:203861..88189913 [GRCh37] Chr9:9p24.3-q21.33 |
pathogenic |
GRCh37/hg19 9p24.3-q34.3(chr9:203862-141020389) | copy number gain | See cases [RCV000512392] | Chr9:203862..141020389 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9p24.3-q34.3(chr9:203861-141020388)x3 | copy number gain | not provided [RCV000845900] | Chr9:203861..141020388 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
Single allele | complex | Glioma [RCV000754871] | Chr9:23524426..87359888 [GRCh37] Chr9:9p21.3-q21.33 |
likely pathogenic |
GRCh37/hg19 9p24.3-q34.3(chr9:10590-141122247)x3 | copy number gain | not provided [RCV000748055] | Chr9:10590..141122247 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9p24.3-q34.3(chr9:10590-141107672)x3 | copy number gain | not provided [RCV000748053] | Chr9:10590..141107672 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9p24.3-q34.3(chr9:46587-141066491)x3 | copy number gain | not provided [RCV000748063] | Chr9:46587..141066491 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9p24.3-q34.3(chr9:10590-141114095)x2 | copy number gain | not provided [RCV000748054] | Chr9:10590..141114095 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9q21.2-22.32(chr9:79520825-97201274) | copy number gain | not provided [RCV000767645] | Chr9:79520825..97201274 [GRCh37] Chr9:9q21.2-22.32 |
pathogenic |
GRCh37/hg19 9q21.11-34.3(chr9:71416475-141020389)x3 | copy number gain | not provided [RCV000847808] | Chr9:71416475..141020389 [GRCh37] Chr9:9q21.11-34.3 |
pathogenic |
Database | Acc Id | Source(s) |
AGR Gene | HGNC:24125 | AgrOrtholog |
COSMIC | FRMD3 | COSMIC |
Ensembl Genes | ENSG00000172159 | ENTREZGENE, UniProtKB/Swiss-Prot |
Ensembl Protein | ENSP00000303508 | ENTREZGENE, UniProtKB/Swiss-Prot |
ENSP00000328615 | ENTREZGENE, UniProtKB/Swiss-Prot | |
ENSP00000365617 | ENTREZGENE, UniProtKB/Swiss-Prot | |
ENSP00000365621 | ENTREZGENE, UniProtKB/Swiss-Prot | |
ENSP00000412719 | UniProtKB/TrEMBL | |
ENSP00000484839 | ENTREZGENE, UniProtKB/Swiss-Prot | |
Ensembl Transcript | ENST00000304195 | ENTREZGENE, UniProtKB/Swiss-Prot |
ENST00000328788 | ENTREZGENE, UniProtKB/Swiss-Prot | |
ENST00000376434 | ENTREZGENE, UniProtKB/Swiss-Prot | |
ENST00000376438 | ENTREZGENE, UniProtKB/Swiss-Prot | |
ENST00000431299 | UniProtKB/TrEMBL | |
ENST00000621208 | ENTREZGENE, UniProtKB/Swiss-Prot | |
Gene3D-CATH | 1.20.80.10 | UniProtKB/Swiss-Prot |
2.30.29.30 | UniProtKB/Swiss-Prot | |
GTEx | ENSG00000172159 | GTEx |
HGNC ID | HGNC:24125 | ENTREZGENE |
Human Proteome Map | FRMD3 | Human Proteome Map |
InterPro | Band_41_domain | UniProtKB/Swiss-Prot |
Ez/rad/moesin-like | UniProtKB/Swiss-Prot | |
FERM-adjacent | UniProtKB/Swiss-Prot | |
FERM/acyl-CoA-bd_prot_sf | UniProtKB/Swiss-Prot | |
FERM_2 | UniProtKB/Swiss-Prot | |
FERM_central | UniProtKB/Swiss-Prot | |
FERM_CS | UniProtKB/Swiss-Prot | |
FERM_domain | UniProtKB/Swiss-Prot | |
FERM_N | UniProtKB/Swiss-Prot | |
FERM_PH-like_C | UniProtKB/Swiss-Prot | |
PH-like_dom_sf | UniProtKB/Swiss-Prot | |
Ubiquitin-like_domsf | UniProtKB/Swiss-Prot | |
KEGG Report | hsa:257019 | UniProtKB/Swiss-Prot |
NCBI Gene | 257019 | ENTREZGENE |
OMIM | 607619 | OMIM |
Pfam | FERM_C | UniProtKB/Swiss-Prot |
FERM_M | UniProtKB/Swiss-Prot | |
FERM_N | UniProtKB/Swiss-Prot | |
PF08736 | UniProtKB/Swiss-Prot | |
PharmGKB | PA134903920 | PharmGKB |
PRINTS | BAND41 | UniProtKB/Swiss-Prot |
ERMFAMILY | UniProtKB/Swiss-Prot | |
PROSITE | FERM_1 | UniProtKB/Swiss-Prot |
FERM_3 | UniProtKB/Swiss-Prot | |
SMART | B41 | UniProtKB/Swiss-Prot |
FERM_C | UniProtKB/Swiss-Prot | |
SM01195 | UniProtKB/Swiss-Prot | |
Superfamily-SCOP | SSF47031 | UniProtKB/Swiss-Prot |
SSF54236 | UniProtKB/Swiss-Prot | |
UniGene | Hs.127535 | ENTREZGENE |
Hs.743606 | ENTREZGENE | |
UniProt | A2A2Y4 | ENTREZGENE, UniProtKB/Swiss-Prot |
Q5JV61_HUMAN | UniProtKB/TrEMBL | |
UniProt Secondary | A8MQB0 | UniProtKB/Swiss-Prot |
B4DN14 | UniProtKB/Swiss-Prot | |
Q53EP2 | UniProtKB/Swiss-Prot | |
Q5JV59 | UniProtKB/Swiss-Prot | |
Q5VZA1 | UniProtKB/Swiss-Prot | |
Q86WP8 | UniProtKB/Swiss-Prot | |
Q8IZ44 | UniProtKB/Swiss-Prot | |
Q8N3Y5 | UniProtKB/Swiss-Prot | |
Q8N9L2 | UniProtKB/Swiss-Prot |
![]() |
More on FRMD3 | |
![]() |
Alliance Gene |
![]() |
NCBI Gene |
![]() |
Ensembl Gene |
![]() |
JBrowse: hg19 hg38 |
![]() |
HGNC Report |
![]() |
NCBI Genome Data Viewer |
CRRD Object Information | |
CRRD ID: | 1312459 |
Created: | 2005-01-12 |
Species: | Homo sapiens |
Last Modified: | 2019-11-26 |
Status: | ACTIVE |
![]() |
![]() |
![]() |
![]() |
RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.